Ascendis Pharma A/S (ASND)

Ascendis Pharma Cash Flow Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Net Income	-232.94	-378.08	-481.45	-583.19	-383.58	-418.96
Depreciation & Amortization	16.88	17.25	18.43	17.51	14.95	9.45
Other Amortization	0.47	0.47	0.48	0.44	0.45	-
Loss (Gain) From Sale of Assets	-	-0.09	0.01	0.02	-	-
Asset Writedown & Restructuring Costs	7.51	-	7.83	-	-	-
Loss (Gain) on Equity Investments	-10.41	20.06	18.4	17.7	-12.04	9.52
Stock-Based Compensation	112.44	95.51	66.66	64.18	66.83	53.17
Other Operating Activities	82.62	45.85	2.07	0.11	-56.53	76.23
Change in Accounts Receivable	-99.66	-118.61	-32.77	-11.53	-6.66	-2
Change in Inventory	-36.6	-86.68	-78.26	-55.27	-75.41	-
Change in Accounts Payable	11.91	26.97	3.55	45.94	39.19	7.88
Change in Unearned Revenue	-1.73	-1.2	-7.08	8.65	5.2	-0.5
Change in Other Net Operating Assets	42.84	72.36	14.77	-0.26	-10.05	-6.36
Operating Cash Flow	-106.68	-306.2	-467.36	-495.7	-417.65	-271.55
Capital Expenditures	-5.48	-1.43	-2.44	-14.49	-23.7	-19.86
Sale of Property, Plant & Equipment	-	0.95	0.05	-	-	-
Sale (Purchase) of Intangibles	-	-	-	-	-0.53	-1.69
Investment in Securities	-0	7.35	288.87	66.69	-86.35	-274.7
Other Investing Activities	-	-	-	9.54	-	5.05
Investing Cash Flow	-5.48	6.88	286.47	61.73	-110.58	-291.2
Long-Term Debt Issued	-	134.16	136.26	503.28	-	-
Long-Term Debt Repaid	-	-11.37	-10.44	-6.36	-6.43	-4.77
Net Debt Issued (Repaid)	-18.07	122.79	125.82	496.93	-6.43	-4.77
Issuance of Common Stock	94.05	340.43	10.29	5.15	379.42	607.42
Repurchase of Common Stock	-28.79	-	-1.81	-105.31	-21.61	-
Other Financing Activities	-19.29	-19.29	-	-	-	-
Financing Cash Flow	27.9	443.93	134.29	396.77	351.39	602.65
Foreign Exchange Rate Adjustments	-2.17	22.77	-6.01	35.69	38.59	-53.49
Net Cash Flow	-86.42	167.38	-52.6	-1.5	-138.25	-13.59
Free Cash Flow	-112.15	-307.62	-469.8	-510.19	-441.35	-291.41
Free Cash Flow Margin	-17.35%	-84.60%	-176.14%	-996.97%	-5674.38%	-4191.11%
Free Cash Flow Per Share	-1.86	-5.31	-8.35	-9.10	-8.06	-5.76
Cash Interest Paid	19.29	15.21	15.67	9.29	1.84	1.5
Cash Income Tax Paid	8.45	5.51	4.47	0	-0.15	-1.1
Levered Free Cash Flow	-64.43	-200.32	-332.95	-156.42	-281.9	-171.19
Unlevered Free Cash Flow	22.9	-159.38	-305.41	-137.24	-279.45	-169.99
Change in Working Capital	-83.25	-107.16	-99.79	-12.47	-47.72	-0.96

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q